The exhibition overview adds impetus to the innovative development of biopharmaceuticals - the 14th Five Year Plan and the 2035 Vision Outline propose to accelerate the development of industries such as biopharmaceuticals, biological breeding, biological materials, and bioenergy, and to expand and strengthen the biopharmaceutical industry. The biopharmaceutical industry is a strategic emerging industry that is related to national economy, people's livelihood, and national security, covering the biotechnology industry, pharmaceutical industry Biomedical engineering produces 50000+exhibition area 30000+professional audience 1000+new product exhibition 50+procurement team 300+exhibiting enterprises 100+mainstream media industry and other aspects. In recent years, guided by favorable policies, China's biopharmaceutical industry has entered a fast lane of development, with a series of new products and services providing new assistance to ensure people's lives and health. Looking at the industry, there has been a significant increase in R&D investment across the entire industry, with thousands of new drugs entering clinical trials and hundreds of new drugs conducting international multicenter clinical trials. The number of approved new drugs is increasing day by day. Looking at enterprises, traditional pharmaceutical enterprises are accelerating their transformation pace, constantly laying out innovative drug research and development, and a large number of emerging biotechnology companies are gradually established and growing rapidly. These innovative entities are important forces in promoting the innovative development of biopharmaceuticals, gathering industry experts and analyzing cutting-edge developments. As of the end of 2022, there are 4120 biopharmaceutical related enterprises in Xi'an High tech Zone, and the scale of the biopharmaceutical industry has exceeded 60 billion yuan, Ranked among the top national high-tech zones in the central and western regions. The China (Xi'an) Biomedical and Technology Equipment Exhibition, hosted by the Airport New City Management Committee of Xixian New Area in Shaanxi Province and hosted by Zhongkai International Exhibition (Beijing) Co., Ltd., will be held on April 25, 2024 at the Xi'an Airport Convention and Exhibition Center. The exhibition will continue to adhere to the development concept of openness, innovation, cooperation, and win-win, continuously explore and break through the innovation of biopharmaceutical technology and industry, promote the development of the medical device industry, and create an innovative leader in China's biopharmaceutical industry. We will comprehensively integrate various forms of activities such as exhibition displays, annual innovative product selection and commendation, summit forums, new product releases, procurement conferences, training and exchanges, and strive to create a cutting-edge platform for showcasing and promoting the biopharmaceutical and related industries to the country and even the world.

Exhibition Scope ◆ Biopharmaceutical Products and Achievements Exhibition Area: comprehensively showcasing the latest products, research achievements, and application development in the field of biopharmaceuticals, inviting biopharmaceutical enterprises in protein drugs, antibody drugs, cell therapy, gene therapy, blood products, and vaccine treatment and prevention; ◆ Exhibition area for biopharmaceutical testing and diagnostic applications: Encourage enterprises and research institutions in gene diagnosis and testing, diagnostic reagents and other testing products, and diagnostic technology applications; ◆ Exhibition area for biopharmaceutical research and development, analysis and manufacturing equipment: biopharmaceutical manufacturing equipment providers, biopharmaceutical research and development, analysis instrument equipment production, suppliers and other related enterprises, scientific research institutions ◆ Exhibition area for biopharmaceutical research and manufacturing supply system: biopharmaceutical raw and auxiliary materials, raw materials and drugs, purification and extraction, enzymes, additives, stabilizers and other industrial chain supply enterprises; ◆ Exhibition area for biopharmaceutical research and development, manufacturing technology services: CXO, exhibiting intellectual property, information consulting, project evaluation, legal consulting, investment and other enterprises and research institutions. 23 ◆ Biomedical and Pharmaceutical Industry Parks and Development Policy Exhibition Area: Various biopharmaceutical industry parks in various regions, publishing policies and investment environments for the development of each park; Discuss the current situation and prospects of industrial development, etc; ◆ Biomedical and Pharmaceutical Talent Exchange Exhibition Area: Exhibition of the image of international and listed companies in the biopharmaceutical industry, recruitment booths for human resources departments, and exhibition of achievements from various universities.

Please contact the exhibition organizer for implementation before participating in the exhibition.

• Company:Zhongkai International Exhibition (Beijing) Co., Ltd
• Truename:Sang Fang
• Mobile:15649211206
• E-mail:120602258@qq.com
• Address:15 Guangren West Road, Airport New City, Xixian New Area, Xianyang City, Shaanxi Province

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870